{"id":837292,"date":"2025-04-15T07:56:15","date_gmt":"2025-04-15T11:56:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-cannabis-introduces-the-companys-first-inhalable-resin-cartridges-for-patients-in-the-united-kingdom\/"},"modified":"2025-04-15T07:56:15","modified_gmt":"2025-04-15T11:56:15","slug":"aurora-cannabis-introduces-the-companys-first-inhalable-resin-cartridges-for-patients-in-the-united-kingdom","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aurora-cannabis-introduces-the-companys-first-inhalable-resin-cartridges-for-patients-in-the-united-kingdom\/","title":{"rendered":"Aurora Cannabis Introduces the Company’s First Inhalable Resin Cartridges for Patients in the United Kingdom"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

NASDAQ | TSX: ACB<\/p>\n

\n
\n Canada’s<\/span> Leading Medical Cannabis Company Expands Patient Offering with Innovative Dosage Solution<\/i>\n <\/p>\n

\n
\n EDMONTON, AB<\/span>
\n <\/span>, April 15, 2025<\/span><\/span> \/PRNewswire\/ – Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the availability of medical cannabis concentrates to patients in the United Kingdom<\/span> (UK). This launch marks the company’s meaningful step in offering its proprietary cultivar-specific inhalable cannabis extracts in the UK market. These products are available to patients in Canada<\/span> and Australia<\/span> and this launch reinforces Aurora’s commitment to expanding patient access to an even greater variety of high-quality, premium medical cannabis globally.<\/p>\n

\n

\n
\n \"Aurora
\n <\/a>\n <\/p>\n<\/p><\/div>\n

“As a company dedicated to patient care and ensuring we regularly listen to patient feedback \u2013 we recognized a real need for a convenient, and discreet consumption option and are excited to introduce a new cannabis format at a promised level of quality,” said Trisha Cassidy<\/span>, Managing Director Aurora UK and Ireland<\/span>. “Our launch of inhalable cannabis cartridges are another step forward in our mission to provide physicians with a larger variety of high-quality medical cannabis that can meet the growing needs and wishes of patients here in the UK. We look forward to receiving feedback from physicians and patients with this expanded offering.” \u00a0<\/p>\n

The two novel cultivar-specific Aurora 1.2g resin cartridges have been developed from two highly sought-after proprietary cultivars: Sourdough (indica) and Electric Honeydew (sativa). The inhalation method of these cartridges offers an ideal solution for fast and controlled delivery of medical cannabis.<\/p>\n

Key benefits of cannabis inhalers include:<\/p>\n